No black box warning on record for Nuedexta

As of the latest FDA labeling reviewed, Nuedexta (DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Nuedexta medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Thrombocytopenia or other hypersensitivity reactions: Discontinue if occurs. ( 5.1 ) Hepatitis: Discontinue if occurs. ( 5.2 ) QT Prolongation: Monitor ECG if concomitant use of drugs that prolong QT interval cannot be avoided or if concomitant CYP3A4 inhibitors used. ( 5.3 ) Left ventricular hypertrophy (LVH) or left ventricular dysfunction (LVD): Monitor ECG in patient

No black box warning on record for Nuedexta

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Thrombocytopenia or other hypersensitivity reactions: Discontinue if occurs. ( 5.1 ) Hepatitis: Discontinue if occurs. ( 5.2 ) QT Prolongation: Monitor ECG if concomitant use of drugs that prolong QT interval cannot be avoided or if concomitant CYP3A4 inhibitors used. ( 5.3 ) Left ventricular hypertrophy (LVH) or left ventricular dysfunction (LVD): Monitor ECG in patient

Nuedexta Black Box Warning

No black box warning on record for Nuedexta

Other warnings & precautions

Nuedexta Black Box Warning

No black box warning on record for Nuedexta

Other warnings & precautions